Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD assures market access to medicines after Brexit
The VMD has confirmed that marketing authorisation holders can continue to be based in the UK and access EU markets.
Document sets out implementation plans for life sciences

Market access to medicines during the Brexit implementation period will not change for the life science sector, the Veterinary Medicines Directorate (VMD) has confirmed.

In a document titled ‘Technical information on what the implementation period means for the life science sector’, the VMD said that marketing authorisation holders can continue to be based in the UK and access EU markets.

‘Manufacturing and distribution licences will continue to be recognised by the EU and vice versa, as will inspections,’ it continued. ‘UK based firms can continue to apply for marketing authorisations via either the centralised or decentralised procedure.’

The VMD adds that a licence for a Centrally Authorised Product (CAP) will be valid for the EU and the UK during the implementation period (29 March 2019 - 31 December 2020).

Products that have not finished a centrally authorised assessment process at the end of the implementation period may have to start again. However, this will depend upon the outcome of negotiations on the UK’s future relationship with the EU.

The assurance comes after concerns were raised by the European Medicines Agency (EMA) about how prepared marketing authorisation holders were for Brexit. A survey by the agency found that just 58 per cent of market authorisation holders for CAPs are on track with their planning for the UK’s exit from the EU.

 

Become a member or log in to add this story to your CPD history

Registrations open for overseas veterinary professionals course

News Story 1
 Registrations are now open for the RCVS CPD course for overseas veterinary professionals, which covers an introduction to the UK veterinary professions.

The course is aimed at overseas-qualified veterinary surgeons and nurses during their first two years of working in the UK, in addition to those considering working here. It provides graduates with the key information and skills required to practice in the UK, as well as helping them understand their legal duties as veterinary professionals.

For more information and to book your place please click here. The course will be held at Belgravia House, London, on Wednesday 12 June.  

Click here for more...
News Shorts
BVA launches award to celebrate young vets

A new award has been launched to celebrate inspirational young vets who are making a difference in their day to day work.

Nominations are now open for the BVA Young Vet of the Year Award, which is the first of its kind. It is open to all vets registered with the RCVS in the first eight years of their careers, working in any veterinary sphere, including clinical practice, research, education or veterinary politics. Organisers are looking for an ‘exceptional young vet’ whose work has benefitted the veterinary community or the workplace.

The awards are open for self-entry and nominations by 1 August 2019. The winner will be announced at London Vet Show on 14 November 2019, where a £1000 cash prize will be awarded, alongside a ‘career enhancing experience’ with Zoetis.